Cycloplegic Refraction in Pediatric Patients With Esotropia
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The primary outcome of this study is to compare cyclopentolate 1% and tropicamide 1% for
cycloplegic refractions in pediatric populations with esotropia. This will be a prospective
double-blinded randomized clinical trial (RCT), multi-center, with randomized sequencing of
cycloplegic agent; each patient received one agent at one visit, and the other agent in the
next visit (2 different visits ≥ 1 week apart) within 3 months.
Phase:
Phase 4
Details
Lead Sponsor:
Islamic Hospital, Jordan
Collaborators:
Jordan University of Science and Technology Yarmouk University